This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

JAMA. 1999;281:1581-1582.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 1999;48:116-121. 2 tables omitted

Colorectal cancer is the second leading cause of cancer-related deaths in the United States.¹ During 1999, approximately 129,400 new cases of colorectal cancer will be diagnosed, and 56,600 persons will die from the disease.¹ In 1996, the U.S. Preventive Services Task Force (USPSTF) recommended the use of specific screening tests (i.e., annual fecal-occult blood testing [FOBT] and/or periodic flexible sigmoidoscopy for persons aged 50 years) to reduce colorectal cancer-related mortality.² In 1997, the American Cancer Society and an interdisciplinary task force developed guidelines that recommend one test or a combination of several tests for colorectal cancer screening.^3-4 To estimate the proportion of the U.S. population that received colorectal cancer screening tests, CDC analyzed data from the 1997 Behavioral Risk Factor Surveillance System (BRFSS) on the use of a home-administered blood stool test, or FOBT, and sigmoidoscopy/proctoscopy. This report summarizes the results of this analysis, which . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Patient Acceptance of CT Colonography and Conventional Colonoscopy: Prospective Comparative Study in Patients with or Suspected of Having Colorectal Disease
Svensson et al.
Radiology 2002;222:337-345.
ABSTRACT | FULL TEXT